Nicotine Patch Trial in Syrian Primary Care Settings

NCT01085032 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

269

Enrollment

OTHER

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Transdermal Nicotine
DRUG: Placebo nicotine patch

Sponsor

University of Memphis